Zhou Lihan is the Executive Director, Co-founder and Chief Executive Officer of MiRXES. Lihan led MiRXESā growth from a 3-man start-up in Singapore to a leader in RNA technology and disease early detection with operations globally.
Prior to founding MiRXES, Lihan led a research team at the Bioprocessing Technology Institute, A*STAR to develop a novel microRNA qPCR assay platform for biomarker and therapeutic target discovery. In 2015, Lihan was recognized by the MIT Technology Review as a member of the Innovators Under 35.
Lihan obtained his Ph.D. in Biochemistry from Yong Loo Lin School of Medicine, National University of Singapore. Lihan has authored and co-authored more than 20 peer-reviewed publications and several patent applications.
Sign up to view 6 direct reports
Get started